A series of novel (4-amino-2-(aryl/alkylamino)thiazol-5-yl)(6-methylbenzo[d]thiazol-2-yl)methanone compounds have been synthesized. They have been characterized by elemental analysis, IR, 1H and 13C NMR and mass spectral techniques. All the synthesized compounds have been screened for their antibacterial potential and show significant antibacterial activity. Among these (4-amino-2-(4-chlorophenyl)amino)thiazol-5-yl)(6-methylbenzo[d]thiazol-2-yl)methanone is more active. Moreover, the compound 3d shows promising antioxidant activity activity. The compounds have been further evaluated for their potential for DNA cleavage and two compounds completely cleaved DNA. Two of the compounds have been evaluated for their anti-proliferative activity against breast cancer cell lines. The IC50 value of the compound (4-amino2-(4-chlorophenyl)amino)thiazol-5-yl)(6-methylbenzo[d]thiazol-2-yl)methanone against the cell line MCF-7 is found to be 10 µg/mL. Four compounds have been docked towards 5077 receptor protein. Molecular docking shows very good interaction with protein. In this (4-amino-2-(4-methoxyphenyl)amino)thiazol-5-yl)(6-methylbenzo[d]thiazol-2-yl)methanone has the highest binding interaction with the protein.

中文翻译：

---

（4-氨基-2-（芳基/烷基氨基）噻唑-5-基）（6-甲基苯并[d]噻唑-2-基）甲酮衍生物的设计、合成、表征、生物分子对接研究和生物活性

合成了一系列新型（4-氨基-2-（芳基/烷基氨基）噻唑-5-基）（6-甲基苯并[d]噻唑-2-基）甲酮化合物。它们已通过元素分析、IR、1H 和 13C NMR 和质谱技术进行表征。所有合成的化合物都经过了抗菌潜力的筛选，并显示出显着的抗菌活性。其中(4-氨基-2-(4-氯苯基)氨基)噻唑-5-基)(6-甲基苯并[d]噻唑-2-基)甲酮活性更高。此外，化合物3d显示出有希望的抗氧化活性。已经进一步评估了这些化合物的 DNA 切割潜力，并且有两种化合物可以完全切割 DNA。已经评估了其中两种化合物对乳腺癌细胞系的抗增殖活性。发现化合物(4-氨基2-(4-氯苯基)氨基)噻唑-5-基)(6-甲基苯并[d]噻唑-2-基)甲酮对细胞系MCF-7的IC50值为10微克/毫升。四种化合物已与 5077 受体蛋白对接。分子对接显示出与蛋白质非常好的相互作用。在这种（4-氨基-2-（4-甲氧基苯基）氨基）噻唑-5-基）（6-甲基苯并[d]噻唑-2-基）甲酮与蛋白质的结合相互作用最高。